Clinical trial
Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy…
NCT00249899 · Takeda, Industry · Terminated
Key facts
| NCT number | NCT00249899 |
|---|---|
| Title | Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia |
| Official title | A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia |
| Lead sponsor | Takeda, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Lapaquistat acetate and stable statin therapy, Stable statin therapy |
| Enrollment | 649 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Nov 7, 2005 |
| Last update posted | May 24, 2012 |
| Countries | Canada, South Africa, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: